West Pharmaceutical Services Other Working Capital increased by 99.1% to -$1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 134.5%, from $2.90M to -$1.00M. Over 4 years (FY 2021 to FY 2025), Other Working Capital shows a downward trend with a 159.1% CAGR.
Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.
Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...
Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.
change_in_other_working_capital| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.60M | -$151.00M | -$19.90M | $50.20M | $48.30M | $32.20M | -$185.40M | $46.80M | $25.30M | -$24.80M | -$53.30M | $34.60M | -$27.00M | $2.10M | -$32.30M | $2.90M | $4.00M | -$2.50M | -$112.50M | -$1.00M |
| QoQ Change | — | -305.2% | +86.8% | +352.3% | -3.8% | -33.3% | -675.8% | +125.2% | -45.9% | -198.0% | -114.9% | +164.9% | -178.0% | +107.8% | <-999% | +109.0% | +37.9% | -162.5% | <-999% | +99.1% |
| YoY Change | — | — | — | — | -34.4% | +121.3% | -831.7% | -6.8% | -47.6% | -177.0% | +71.3% | -26.1% | -206.7% | +108.5% | +39.4% | -91.6% | +114.8% | -219.0% | -248.3% | -134.5% |